Wednesday, October 28, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed Everything

Ten years ago, Eli Lilly ( NYSE:LLY | LLY Price Prediction ) was a steady Indianapolis drugmaker known for insulin and a dependable dividend. In its 150th year, it now carries a…

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 16 03:00 ETSource: 24/7 Wall St.

From the source

A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed Everything

Ten years ago, Eli Lilly ( NYSE:LLY | LLY Price Prediction ) was a steady Indianapolis drugmaker known for insulin and a dependable dividend. In its 150th year, it now carries a market cap of roughly $1.117 trillion. The incretin era rewrote the company.

Read at 247wallst.com
PeptiPrescribed peptides from $99/moSee all →